OPYS Telehealth Blog Series March 8, 2022 Issue No. 3 Broadband access is the foundation of telehealth and virtual healthcare services. Without it, your program is like a like a sandcastle, built in the sand, that can be easily washed away by the ocean. When a patient is trying to access virtual healthcare, spotty or inadequate broadband speeds … [Read more...]
Ivermectin, a medication that has long been approved by the U.S. Food and Drug Administration (FDA) and World Health Organization (WHO) to fight parasites and treat worm infections, has been a topic of controversy during the COVID-19 pandemic. Some experts have argued that public messages about ivermectin could lead people to use ivermectin that is … [Read more...]
The speed with which the COVID-19 vaccines were developed raised concerns among healthcare professionals and the general public alike regarding both the long-term efficacy and safety of the vaccines. Though certain vaccines were granted emergency use authorization given the gravity of the public health crisis, efficacy and safety data have been … [Read more...]
Artificial intelligence (AI) has transformed many industries, at times replacing entire jobs that were previously performed by humans. While medicine relies on innovative technology to a significant extent, AI has yet to majorly disrupt the practice of medicine itself. Many applications of AI, for example, have been applied to administrative tasks … [Read more...]
Treatment and vaccine options for COVID-19 have been aggressively investigated this year as the world grapples with the pandemic. Several new publications in the medical journal JAMA have provided data that support the idea that corticosteroids may increase the chances of survival in people who become critically ill with COVID-19. In one of the … [Read more...]
